Inactive Instrument
Precision Therapeutics Inc Stock Nasdaq
Stocks
US74033P1003
Biotechnology & Medical Research
| Market Cap | 83.34M 72.21M 67.65M 61.71M 116M 7.95B 118M 796M 311M 3.98B 313M 306M 13.27B | P/E 2024 |
-0.35x | P/E 2025 | -0.53x |
|---|---|---|---|---|---|
| Enterprise Value | 74.22M 64.3M 60.25M 54.95M 103M 7.08B 105M 709M 277M 3.54B 279M 273M 11.82B | EV / Sales 2024 |
4.23x | EV / Sales 2025 | 121x |
| Free-Float |
94.34% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Precision Therapeutics Inc
| 1 day | -7.56% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 09/02/2026 | |
| Director of Finance/CFO | - | 16/04/2026 | |
Kyle Okamoto
PSD | President | - | 01/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Handley
BRD | Director/Board Member | 66 | 19/02/2020 |
Charles L. Nuzum
CHM | Chairman | 78 | 09/02/2026 |
| Director/Board Member | 60 | 09/07/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.56% | -8.33% | - | - | 83.34M | ||
| -1.60% | +0.86% | +3.70% | +14.57% | 49.54B | ||
| -0.05% | +4.79% | +486.36% | +589.17% | 44.06B | ||
| -0.30% | +9.63% | +24.64% | +75.91% | 40.85B | ||
| -0.27% | +2.99% | +30.77% | +10.45% | 40.14B | ||
| -4.04% | +8.72% | +22.60% | +48.00% | 34.17B | ||
| -0.49% | +2.31% | +30.93% | +126.39% | 16.9B | ||
| +0.92% | +5.83% | - | - | 16.78B | ||
| -0.43% | -0.11% | +4.22% | +20.71% | 14B | ||
| +1.54% | +9.71% | +87.25% | +31.87% | 13.46B | ||
| Average | -1.15% | +6.97% | +86.31% | +114.63% | 29.99B | |
| Weighted average by Cap. | -0.71% | +6.51% | +104.22% | +137.07% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.62M 1.41M 1.32M 1.2M 2.26M 155M 2.3M 15.5M 6.06M 77.55M 6.1M 5.96M 259M | 125K 109K 102K 92.76K 174K 11.95M 177K 1.2M 468K 5.98M 470K 460K 19.95M |
| Net income | -12.66M -10.97M -10.28M -9.38M -17.63M -1.21B -17.9M -121M -47.26M -605M -47.55M -46.52M -2.02B | -233M -202M -189M -173M -324M -22.23B -329M -2.23B -870M -11.13B -875M -856M -37.12B |
| Net Debt | 1.4M 1.21M 1.13M 1.03M 1.94M 133M 1.97M 13.33M 5.21M 66.68M 5.24M 5.13M 222M | -9.12M -7.91M -7.41M -6.76M -12.7M -870M -12.9M -87.12M -34.05M -436M -34.26M -33.51M -1.45B |
Employees
-
Calendar

















